Up to 5.3 million doses of the Covid-19 vaccine from the British pharmaceutical group AstraZeneca will be delivered to Switzerland if the ongoing trials are successful, the Federal Office of Public Health said on Friday.
Switzerland has signed a contract with the company AstraZeneca and the Swedish government for the delivery of up to 5.3 million doses of the vaccine against Covid-19. The contract is part of an agreement between the European Commission and AstraZeneca.
The agreement between the European Commission and AstraZeneca on the delivery of up to 400 million doses in Europe forms the basis of the contract, the Federal Office of Public Health (OFSP) said in a press release on Friday. Sweden will order the doses for non-EU EEA and EFTA countries and sell them back to the corresponding states without profit.
Delivered directly to Switzerland
If the ongoing trials are successful and approved, AstraZeneca’s vaccine, AZD1222, will be shipped directly to Switzerland, the Swiss branch of the British pharmaceutical company said in a statement. At the beginning of October, AstraZeneca had already submitted an authorization request to Swissmedic.
The FOPH indicates that the Confederation is pursuing a diversified strategy, not knowing which vaccines will be necessary. It is also negotiating with other pharmaceutical manufacturers, in order to be able to quickly provide a vaccine against the new coronavirus to the Swiss population.